学会発表 総説論文（英文） 1. Takizawa S, Matsuzaki J, Ochiya T. 国内学会発表 木村真規, 金子裕稀，石塚菜那帆，是枝泰介，松崎潤太郎，齋藤義正 The legacy effect of exercise on senescence related gene expressions in visceral adipose tissue of young mice. 日本生理学会 第100回記念大会 2023年3月 京都 山口智子、松崎 潤太郎、落谷 孝広 Engineering of human liver progenitor-like cells for a new exosomal therapy of liver fibrosis 第30回日本消化器関連学会週間, 2022年10月 福岡 薬物治療学講座 7 薬物治療学講座 103 carcinoma. CCaanncceerr SScciieennccee 113:3510-3517, 2022. 5. Urabe F, Matsuzaki J, Ito K, Takamori H, Tsuzuki S, Miki J, Kimura T, Egawa S, Nakamura E, Matsui Y, Fujimoto H, Yamamoto Y, Ochiya T. Serum miRNAs as liquid biopsy biomarker for the prediction of oncological outcomes in patients with bladder cancer. IInntteerrnnaattiioonnaall JJoouurrnnaall ooff UUrroollooggyy 29:968-976 (2022) Inokuchi K, Mori H, Matsuzaki J, Hirata K, Harada Y, Saito Y, Suzuki H, Kanai T, Masaoka T Efficacy and safety of low-dose rifabutin-based 7-day triple therapy as a third- or later-line Helicobacter pylori eradication regimen. HHeelliiccoobbaacctteerr 27:e12900, 2022. 6. 7. Takamori H, Urabe F, Matsuzaki J, Kimura S, Sasaki H, Kimura T, Inaba K, Nakamura E, Matsui Y, Fujimoto H, Ochiya T. Circulating microRNA profiling for prediction of oncological outcomes in prostate cancer patients following radical prostatectomy. TThhee PPrroossttaattee 82:1537-46 (2022) 8. Miura T, Mitsunaga S, Matsuzaki J, Takizawa S, Kato K, Ochiai A, Ochiya T. Serum microRNAs as new criteria for referral to early palliative care services in treatment-naïve advanced cancer patients. OOnnccoottaarrggeett 13:1341-49 (2022) Circulating microRNAs: challenges with their use as liquid biopsy biomarkers. CCaanncceerr BBiioommaarrkkeerrss 35:1-9 (2022)
元のページ ../index.html#107